PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
-
Published:2022-03-21
Issue:4
Volume:28
Page:724-734
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Narayan VivekORCID, Barber-Rotenberg Julie S., Jung In-Young, Lacey Simon F., Rech Andrew J., Davis Megan M., Hwang Wei-TingORCID, Lal Priti, Carpenter Erica L.ORCID, Maude Shannon L., Plesa Gabriela, Vapiwala Neha, Chew Anne, Moniak Michael, Sebro Ronnie A., Farwell Michael D., Marshall Amy, Gilmore Joan, Lledo Lester, Dengel Karen, Church Sarah E.ORCID, Hether Tyler D., Xu Jun, Gohil Mercy, Buckingham Thomas H., Yee Stephanie S.ORCID, Gonzalez Vanessa E., Kulikovskaya Irina, Chen FangORCID, Tian LifengORCID, Tien Kyle, Gladney Whitney, Nobles Christopher L.ORCID, Raymond Hayley E., Frazee Diane, Truran Mary, Veloso Elizabeth, McConville Holly, Aguedelo Jonathan, Hower Samantha, Ngo Sophia, Jadlowsky Julie, Melenhorst J. Joseph, Roche Aoife, Everett John, Gupta Minnal, Nazimuddin Farzana, Bartoszek Chelsie, Koterba Natalka, Reynolds Rachael, Ellington Farris, Kloss Christopher C., Lee Jihyun, Zhao Yangbing, Scholler John, Riley James L., Bailey Christina, White Andrew, Hudson Briana, Chang Pearl, Maus Marcela V., Levine Bruce L., Hexner Elizabeth O., Siegel Donald L.ORCID, Bushman Frederic D.ORCID, June Carl H.ORCID, Fraietta Joseph A.ORCID, Haas Naomi B.ORCID,
Funder
Prostate Cancer Foundation Alliance for Cancer Gene Therapy U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference82 articles.
1. Lu, X. et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature 543, 728–732 (2017). 2. Venkatachalam, S., McFarland, T.R., Agarwal, N. & Swami, U. Immune checkpoint inhibitors in prostate cancer. Cancers (Basel) 13, 2187 (2021). 3. Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. New Engl. J. Med. 378, 439–448 (2018). 4. Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. New Engl. J. Med. 371, 1507–1517 (2014). 5. Schuster, S. J. et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. New Engl. J. Med. 377, 2545–2554 (2017).
Cited by
154 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|